HRT Made Me Feel Worse: Side Effects and What to Do

When treatment brings new symptoms, a careful review is more useful than being told to endure it—or assuming you must give up on every option.

The night sweats settle. Then you notice sore breasts, bloating or an unfamiliar edge to your anxiety. It can be difficult to describe the result as an improvement when there’s a new problem to deal with. A review starts by comparing what changed, when it changed and which symptoms HRT was intended to treat. Some effects can occur together, and a new symptom may have a separate cause.

Start with the timeline, rather than the hormone theory

Write down what changed and when: starting treatment, increasing estrogen, adding progesterone, switching brands or moving from a patch to tablets. Record the exact product, strength, route and schedule. “I take two hormones” leaves too much room for misunderstanding, especially when a combined product already contains both.

Then describe the symptoms in ordinary terms. Feeling sleepy after a bedtime capsule is different from waking panicky at 4 a.m.; a mild headache is different from a new neurological symptom. Note what improved as well. If sweats have stopped but mornings are still exhausting, the next question may concern sleep apnea or a sedating medicine rather than inadequate estrogen.

How long should you give it?

Breast tenderness, nausea and spotting are recognized adverse effects of hormone therapy, and some early effects settle. The Menopause Society’s hormone-therapy information describes reviewing the dose or preparation when adverse effects are troublesome. A treatment that is suitable for many women can still be difficult for an individual to tolerate.

NICE recommends review at about three months to assess benefit and tolerability, with earlier review when side effects or other concerns warrant it. Three months is a review point, not an instruction to remain miserable or ignore red flags until a deadline. Contact the prescriber sooner if symptoms are severe, worsening or affecting your ability to function.

Anxiety, irritability or low mood after starting HRT

A close connection with a prescription change deserves attention, but it does not prove that you have “too much estrogen” or “low progesterone.” Sleep loss, perimenopausal fluctuations, depression, thyroid disease, other medicines and life circumstances can overlap. Some people notice a reproducible change during the progesterone part of a sequential regimen; others do not.

Bring a brief record of mood, sleep and treatment days rather than trying to diagnose the mechanism from a symptom chart online. A clinician may review the formulation, schedule or dose and assess whether anxiety or depression also needs treatment in its own right. Hormone therapy is not a substitute for appropriate mental-health care.

Rapidly worsening depression, thoughts of self-harm, feeling unable to stay safe, marked agitation or possible mania require urgent professional assessment. Seek emergency care if safety is in immediate danger. These are not ordinary adjustment symptoms to manage by experimenting with hormone doses.

Could progesterone be part of the problem?

Oral micronized progesterone can cause drowsiness or dizziness; for some women the next morning feels like a hangover. Others find it helpful for sleep. The Canadian Prometrium product monograph warns that food can increase exposure and that somnolence or dizziness may occur after ingestion, particularly with food. Follow the directions for your actual product and prescription; ask a pharmacist if the food or timing advice is unclear. Do not copy another country’s brand instructions or another patient’s dose.

Daily and sequential regimens have different purposes, and the amount of progestogen needed depends on the estrogen regimen and clinical circumstances. With a uterus, systemic estrogen generally requires adequate endometrial protection. Do not simply stop the progesterone while continuing systemic estrogen, replace it with an unverified cream or change an oral capsule to a vaginal route yourself. Discuss a safe alternative if tolerability is poor. Our progesterone side-effects guide covers that conversation in detail.

Would a patch or gel be easier than a tablet?

Possibly, but the answer is individual. Oral estrogen passes through the liver first; transdermal estrogen is absorbed through the skin. That difference affects clotting risk and some metabolic effects. It does not mean that a patch is free of systemic effects or that a gel guarantees better mood. A patch may irritate the skin; a gel has application and transfer precautions that need to be followed.

Canadian clinical guidance on menopause treatment describes oral and transdermal options and the need for uterine protection with systemic estrogen. Our Canadian MHT guide covers formulations and prescribing more broadly. Product choice should account for your medical history as well as comfort.

Canadian supply note, November 2026: Health Canada reported shortages of some estradiol patch strengths on November 4, with intermittent shortages expected into early 2027. Local stock changes. Ask your pharmacist and prescriber to coordinate alternatives; the number printed on a patch is not directly interchangeable with the number on a tablet or gel. Avoid unlicensed online sellers and improvised substitutions.

Headaches and migraine need a more specific conversation

Hormonal changes can influence migraine, and a treatment change may improve or worsen attacks. Describe whether the headache resembles your usual migraine and whether aura is new or different. Check blood pressure and other possible contributors with your clinician rather than assuming the prescription explains everything.

Migraine with aura does not automatically carry the same prescribing rules for menopausal HRT as for combined hormonal contraception. The British Menopause Society’s migraine guidance favours non-oral estrogen at the lowest effective dose when HRT is appropriate, to avoid unnecessary fluctuations. Your vascular risk and medical history still matter. A thunderclap headache or new weakness, speech difficulty or loss of vision requires emergency assessment, not a routine dose discussion.

Bloating, breast symptoms and symptoms that persist

Breast tenderness or nausea may be treatment-related, but do not use that possibility to explain away a new breast lump, spontaneous or bloody nipple discharge, marked one-sided changes or persistent focal pain. Arrange assessment. Likewise, persistent or progressive abdominal bloating, early fullness, significant pain or unexplained weight change deserves its own review.

If the main problem is continued hot flashes, check practical use first: missed doses, patch adhesion, the correct application site and product-specific gel instructions. Ask the pharmacist to check technique. The BMS prescribing statement cautions against chasing a universal systemic estrogen target. Symptoms alone do not tell you whether a dose must go up or down, and routinely ordering commercial hormone panels will not settle every tolerability question.

For ongoing exhaustion, our fatigue guide covers iron deficiency, thyroid disease, sleep apnea, medicines and other possibilities. For persistent insomnia, see the sleep guide. HRT can be useful without being sufficient for every midlife symptom.

Bleeding is a separate safety question

Some sequential regimens produce a planned withdrawal bleed, and unscheduled spotting can occur after starting or changing treatment. Nevertheless, unexpected postmenopausal bleeding should be reported and assessed according to the regimen, timing and individual risk. Heavy, prolonged or recurrent bleeding, or bleeding after an established bleed-free interval, deserves particular attention. Do not assume that taking HRT makes it harmless.

Our Canadian bleeding-assessment guide explains the pathway. Early adjustment windows are not blanket permission to ignore bleeding, especially when it is heavy or other risk factors are present.

Make the review useful

Bring the prescription details, the start and change dates, the symptoms that improved and the symptoms that did not. Include other medicines, supplements, bleeding and any effect on work, driving or safety. Then ask:

• Does the timing suggest a side effect, an untreated symptom or a separate condition?
• Is the route, dose and progestogen plan appropriate for my history?
• If we change something, what benefit or adverse effect are we watching for?
• How will uterine protection be maintained if progesterone is difficult to tolerate?
• When should we review, and what should make me contact you sooner?

Where clinically appropriate, changing one thing at a time makes the outcome easier to interpret. The plan might include another formulation, a different schedule, investigation of another illness or nonhormonal treatment. If difficulties continue, request a clinician with menopause expertise.

You do not have to prove that HRT is either wonderful or terrible. You need a treatment plan whose benefits are worth its burdens for you—and a prescriber willing to take both seriously.

Educational information, not individualized prescribing advice. Evidence and Canadian information reviewed November 6, 2026.

For a concise record before the review, use the existing 14-day symptom and HRT diary. Note what improved, what worsened and the dates of treatment changes. Do not wait to complete it before seeking help for a concerning symptom.